Navigation Links
US Patent Granted for a New Family of Heat Shock Protein 90 (Hsp90) Inhibitors for the Treatment of Cancer and Neurodegenerative Indications
Date:5/19/2011

NEW YORK, May 19, 2011 /PRNewswire/ -- NexGenix Pharmaceuticals Inc., a privately-held company developing treatments for cancer, neurodegenerative diseases, and orphan neurogenetic disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a key patent for a platform of Hsp90 inhibitors based on derivatives of the  naturally occurring pochonin family, Pochonia chlamydospora.  The platform of fully synthetic small molecules covered by this composition of matter patent was developed in the laboratory of Dr. Nicolas Winssinger at the University of Strasbourg (UNISTRA) and is exclusively licensed to NexGenix.

The patent, entitled "Macrocyclic Compounds Useful as Inhibitors of Kinases and Hsp90", provides an exclusivity period until August 2027.  The patent specifically covers the proprietary scaffold and its composition along with a large library of compounds, including NexGenix's lead Hsp90 inhibitors aimed at cancer and neurodegenerative indications.  The pochonin scaffold represents an advancement in Hsp90 inhibition beyond several molecules developed over the last decade based on radicicol and geldanamycin derivative (17-AAG) which have been shown to exhibit highly potent anti-tumor activity in numerous pre-clinical and clinical studies.

Professor Nicolas Winssinger of UNISTRA stated, "Through a research collaboration agreement with NexGenix in 2007, we have developed a library of hundreds of molecules based on the scaffold that is covered by the patent allowed by USPTO. These molecules have been developed through an iterative process based on extensive in vitro and in vivo studies conducted by NexGenix in the selection of a lead candidate. I am looking forward to continuing these collaborative development activities."

X-ray crystallography studies have demonstrated deeper binding of NexGenix's molecules to the Hsp90 ATP binding pocket compared to other small-
'/>"/>

SOURCE NexGenix Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Landmark Patents Issued for ViewRay Technology
2. Breckenridge Pharmaceutical Announces Settlement of Actos® (Pioglitazone Hydrochloride) Patent Litigation
3. GT Life Sciences Broadens Intellectual Property Portfolio with Issuance of U.S. Patent on Core Computational Systems and Methods for Genomic-based Metabolic Modeling
4. Boston Scientific Announces Favorable Jury Verdict Against Cordis Corporation in Stent Patent Litigation
5. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
6. AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period
7. Rosetta Genomics Announces Issuance of Additional U.S. Patent
8. Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film
9. IRIDEX Granted U.S. Patent for Stepped Angled Laser Handpieces Used in Eye Surgery
10. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
11. Reportlinker Adds Pharmaceutical Key Trends 2011 - Brand Erosion Post-Patent Expiry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: ... results for its first quarter ended December 31, 2014. ... 31, 2014, revenue was $1,336,685. Operating expenses were $1,063,393. ... per share.  Covalon,s President and CEO, ... with the significant progress we have made over the ...
(Date:2/27/2015)... 2015  Uroplasty, Inc. (NASDAQ: UPI ), a ... proprietary products to treat voiding dysfunctions, today announced that ... on Tuesday, March 10, 2015. Rob Kill , ... Financial Officer, will present at 4:00 p.m. Pacific Time ... conference at the Ritz Carlton in Laguna ...
(Date:2/26/2015)... Calif. , Feb. 27, 2015  Finesse expands office ... Finesse Solutions announced the expansion of its operations ... is planned for mid-March and access for customers is ... the A-563, and located adjacent to the current office, ... the Finesse automation engineering team and allow Finesse to bring ...
Breaking Medicine Technology:Covalon Announces First Quarter Financial Results 2Covalon Announces First Quarter Financial Results 3Uroplasty to Participate in the 27th Annual ROTH Conference 2New Finesse Office in United Kingdom 2
... WASHINGTON, Feb. 9, 2012   The Pharmaceutical Care ... in Pennsylvania that highlights the core value proposition of pharmacy ... What PBMs Do" – focuses on key themes ... and consumers. , PBM mail-service pharmacies improve safety, savings, ...
... Feb. 9, 2012  As part of its ongoing restructuring ... of its subsidiaries as wholly owned subsidiaries of iMD ... time, a wholly owned subsidiary of Optimum Mobile Imaging ... Hyper-Interactive Marketing LLC, will now reside alongside the newly ...
Cached Medicine Technology:PCMA Launches New Pennsylvania Ad Campaign: 'That's What PBMs Do' 2Optimum Mobile Imaging Corp. (ICBU) Retains Securities Law Firm 2
(Date:2/27/2015)... The Nashville periodontist office, ... for rising freshmen undergraduate students. , The Advanced Institute ... in many periodontal procedures such as dental implants ... disease . In honor of their 25th anniversary, AIOH ... rising freshmen undergraduate students. , Students interested in ...
(Date:2/27/2015)... February 27, 2015 Insight Accelerator ... to advance the development of an in-line urine ... solution is being developed in direct response to ... 73% accuracy and error margins with potentially grave ... output measurement and provide trending data analysis to ...
(Date:2/27/2015)... 2015 Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ... suffered uterine perforations and other serious harm due to ... move forward in the multicounty litigation underway in New ... Court records indicate that the proceeding’s 34th Case ... Conference convened that same day. (In Re: Mirena Litigation; ...
(Date:2/27/2015)... Over 440,000 patients die annually as a ... two jumbo jet airplanes crashing each day. Now more than ... an effort to do all they can to stay safe. ... the 17th U.S. Surgeon General, discusses the importance of safer ... to address safety issues to ensure that all our patients ...
(Date:2/27/2015)... New York, NY (PRWEB) February 27, 2015 ... Cole Tickets for his "Forest Hills Drive Tour Act ... third album "2014 Forest Hills Drive" which debuted on the ... selling hip-hop album. In March, this accomplished hip-hop artist ... begins in early March and will visit cities such as ...
Breaking Medicine News(10 mins):Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Output Medical Joins Insight Accelerator Labs 2Health News:Output Medical Joins Insight Accelerator Labs 3Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Dr. Richard Carmona, the 17th U.S. Surgeon General, and IntelliCentrics Raise Awareness in Mediaplanet’s “Patient Safety” Campaign 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 2Health News:J. Cole Tickets in Los Angeles, Mountain View, Chula Vista, New York, Chicago, Indianapolis, Holmdel, Dallas, Seattle, Camden, Bristow, Atlanta, Houston & Detroit On Sale 3
... QC, Nov. 21 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: ... a written response from,the U.S. Food and Drug ... Letter for its once-daily tramadol formulation through,the Formal ... Director,of the Office of Drug Evaluation II, Center ...
... predict the spread of emerging diseases has been developed ... model, described in the online open access journal BMC ... path an emerging disease might take and so might ... respiratory syndrome (SARS) spread rapidly in 2002-2003, revealing just ...
... SYDNEY, Australia, Nov. 20 Open access ... Online) has released a special,nanotubes research edition ... research project that has been investigating the ... and nanotube,arrays for industrial applications., ...
... Calif., Nov. 20 NNN Healthcare/Office REIT,Inc. ... closed on,November 15, 2007. Northmeadow Medical ... building in the Atlanta suburb of Roswell,Georgia. ... the property is,strategically located directly across the ...
... for,being at the vanguard of social change. Within the ... the scope of the state,s health care,system into something ... current push to approve the new Health Care Reform ... that will answer the,question of how effective health care ...
... 20 WELLESSE ALL DAY Energy(TM) is,a proud sponsor ... be showcasing WELLESSE ALL DAY Energy -- your ,healthy ... WELLESSE ALL DAY Energy is a take anywhere ... endurance.(+) You may be a marathon athlete, a ...
Cached Medicine News:Health News:Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol 2Health News:SARS: a model disease 2Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 2Health News:NNN Healthcare/Office REIT Acquires Northmeadow Medical Center in Roswell, Georgia 3Health News:California's Huge Health Care Opportunity 2Health News:WELLESSE ALL DAY ENERGY(TM) - Sponsors of the UW Medical Center 2007 Seattle Marathon 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: